LCMV (221-228), GP221 is a defined epitope from the LCMV glycoprotein used to characterize CD8⁺ T-cell responses. Its sequence supports stable MHC binding and controlled antigen presentation. Researchers employ it in clonal expansion and cross-reactivity studies. The peptide aids mechanistic analysis of antiviral cellular immunity.
CAT No: M07030
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More